News

Congratulations! A patent by Dr. Elizabeth Sweeney and her collaborators on nanoparticle-based anti-cancer therapy was granted.

Dr. Sabysachi Sen was appointed as the Chief of Endocrinology for the Veterans Affairs Medical Center, Washington DC.

Dr. Brett Shook presented his research findings at the Fusion Conference on Growth Factors in Regeneration and Regenerative Medicine in Cancun, Mexico.

Dr. Wenge Zhu was appointed as the leader of the GW Cancer Center Molecular Therapeutics Focus Group.

Dr. Jonathon Keeney and Dr. Patrick McNeely won the first prize of the LitCoin Pilot Design Challenge.

Drs. Patricia Berg, Valerie Hu, Rong Li, and William Weglicki became members of the GW Chapter of the National Academy of Inventors (NAI).

A patent based on the work from Dr. William Weglicki’s team has led to a Phase 2a clinical trial of HT-001 for the treatment of skin toxicities associated with Epidermal Growth Factor Receptor Inhibitors (EGFRi).

A patent based on the work from Dr. Rong Li’s team has led to a Phase 1 clinical trial PRTH-101, a Novel DDR1 Inhibitor for the Treatment of Immune-Excluded Solid Tumors.

Dr. Wenge Zhu received the 2023 GW Cancer Center Award for Outstanding Scientist.

Dr. Jiyoung Lee received the 2023 GW Cancer Center Award for Junior Faculty Research.